Medicine and Dentistry
Magnetic Resonance Angiography
100%
Atheroma
90%
Therapeutic Procedure
90%
Evaluation Study
90%
Whole Body MRI
90%
Ankle Brachial Index
90%
Cross Sectional Study
90%
Liver Cirrhosis
90%
Intima-Media Thickness
90%
Patient
38%
Portal Hypertension
29%
Vasoconstriction
29%
Inpatient
29%
Endothelial Dysfunction
19%
Kidney Perfusion
19%
Artery Blood Flow
19%
Kidney Blood Flow
19%
Peptide Receptor
19%
Kidney Function
19%
Arteriosclerosis Obliterans
18%
Rest
18%
Neck
18%
Infusion
9%
Volunteer
9%
Alcohol
9%
Terlipressin
9%
Scar Formation
9%
Family
9%
Vasodilatation
9%
Renal Artery
9%
Male
9%
Female
9%
Intravenous Drug Administration
9%
Combination Therapy
9%
Glomerular Filtration Rate
9%
Signal Transduction
9%
Vasoconstrictor
9%
Adverse Event
9%
Blood Pressure
9%
Kidney Vascular Resistance
9%
Liver
9%
Perfusion
9%
Deterioration
9%
Hepatorenal Syndrome
9%
Acute Kidney Injury
9%
Peptide
9%
Kidney
9%
Relaxin
9%
Atherosclerosis
9%
Arterial Stiffness
9%
Occlusion
9%
Multiple Linear Regression Analysis
9%
Disease Marker
9%
Gadolinium
9%
Magnetic Resonance Imaging
9%
Biochemistry, Genetics and Molecular Biology
Electric Potential
90%
Rat Model
29%
Vasoconstriction
29%
Kidney Perfusion
19%
Artery Blood Flow
19%
Kidney Function
19%
Kidney Blood Flow
19%
Relaxin
19%
Reduction (Chemistry)
19%
Sample Size
9%
Normal Human
9%
Molecule
9%
Vasodilatation
9%
Kidney Vascular Resistance
9%
Liver Perfusion
9%
Contrast
9%
Terlipressin
9%
Oxygenation
9%
Peptide
9%
Glomerulus Filtration
9%
Blood Pressure
9%
Scar Formation
9%
Signal Transduction
9%
Magnetic Resonance Angiography
9%
Pharmacology, Toxicology and Pharmaceutical Science
Liver Cirrhosis
90%
Serelaxin
90%
Rat Model
29%
Clinical Study
29%
Portal Hypertension
29%
Endothelial Dysfunction
19%
Scar Formation
9%
Adverse Event
9%
Vasoconstrictor Agent
9%
Peptide
9%
Receptor
9%
Terlipressin
9%
Ethanol
9%
Normal Human
9%
Relaxin
9%
Deterioration
9%
Acute Kidney Failure
9%
Hepatorenal Syndrome
9%